keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Day Two – 11 June 2024 - CEST (Cent Europe Summer, GMT+2)
keyboard_arrow_leftSearch & Filter
search
Streams
Day Two – 11 June 2024 - CEST (Cent Europe Summer, GMT+2)
search
Streams
07:30 - 08:30
Conference Registration
Showing 3 of 3 Streams
European Medical Device Regulations
Biocompatibility Workshop: Biological Evaluation Execution & Authorship Training
In Vitro Diagnostic Regulations
08:30 - 08:40
Chairperson’s Opening Remarks: European Medical Device Regulations
- James Shearn - Director, Regulatory & Quality Compliance (EMEA), Steris
08:40 - 09:40
Optimising the Regulatory Space: A New World of MDR?
- A review of the current regulatory ecosystem within Europe
- Is this the most effective way to get devices onto the market?
- What hurdles are there with the current system?
- Which solutions are there for increasing efficiency?
- The future of regulatory
- What opportunities and risks are there with a more centralised approach?
- How would this affect regulatory teams?
- What would the knock-on affect for the wider population be?
- Erik Vollebregt - Partner, Axon Lawyers
- Alice Forde - Director, Regulatory Affairs Europe at Bausch & Lomb., Bausch & Lomb
- Oliver Hartmann - Regulatory and Legal Affairs Director, Association of the European Self-Care Industry (AESGP)
09:40 - 10:10
Device Registry in Europe: EUDAMED & Beyond
EUDAMED is coming with mandatory usage from Q4 2025, do not be fooled it takes a long time to correctly prepare for EUDAMED. This session will highlight some of the pitfalls, experiences to date, and what is needed to submit your data to EUDAMED while keeping budgets as low as possible.
- Richard Houlihan - Founder & CEO, EirMed
10:10 - 10:40
MDR: Is It Really as Bad as You Think?
- Experience with MDR as of today
- Challenge(s) accepted! How far are the solutions?
- Perspectives on running a study in the EU
- Amie Smirthwaite - Senior Vice President, Scientific Affairs, RQM+
09:00 - 09:10
Chairperson’s Opening Remarks: Biocompatibility Workshop
- Beau Rollins - Director, Quality Services, ConvaTec
- Marina Daineko - Biocompatibility Consultant, Intrinsic Medical Group, LLC
09:10 - 10:40
I: Foundations to Biological Evaluations
- The beginnings of the BE
- Intent of a BE
- Definitions and foundations
- Standard intent vs regulator interpretation
- Beau Rollins - Director, Quality Services, ConvaTec
08:30 - 08:40
Chairperson’s Opening Remarks: In Vitro Diagnostic Regulations
- Stuart Angell - Chair of Regulatory Affairs Working Party & Member of the Executive Board, BIVDA
08:40 - 09:40
Multi-Stakeholder Panel: IVDR & The Transition Deadlines
- Current status of diagnostics certified under IVDR
- Is there set to be a shortage of diagnostics in Europe?
- How are diagnostic and pharma companies coping with the regulations?
- Upcoming deadlines
- What has changed for all parties now the deadlines have been extended?
- Do all manufacturers classify for the extensions or is there criteria to qualify?
- Do these extensions mean people can ‘take their foot off the gas’?
- Andreas Stange - Senior Vice President MHS Regulatory & Quality, TÜV SÜD Product Service GmbH
- Patrick Fivey - Director of Precision Medicine Policy, AstraZeneca
- Vihanga Pahalawatta - Director Regulatory Affairs Companion Diagnostics, AbbVie
- João Martins - Associate Director Regulatory Affairs Strategy, Abbott
- Elizabeth Dequeker - Head of the Biomedical Quality Assurance Research Unit, University of Leuven
09:40 - 10:10
Forecasting the Near Future: Placing IVDs on the UK Market
- With the new UK regulation coming into force from July 2025, what can we expect for placing IVDs on this market?
- Status of approved bodies
- Timelines for manufacturers
- Transition periods
- Timelines from documentation submission to gaining approval
- Stuart Angell - Chair of Regulatory Affairs Working Party & Member of the Executive Board, BIVDA
10:10 - 10:40
State of Play for IVDs in Switzerland
- Current status of regulations for IVDs in Switzerland
- Comparison with rest of Europe
- Case study: end-to-end process of gaining approval
- Common pitfalls and solutions
- Status of FDA approved products for Switzerland
- Jessica Ruperto - Senior Regulatory Affairs Specialist, Thermo Fisher Scientific
10:40 - 11:10
Coffee and Networking Break
Showing 3 of 3 Streams
European Medical Device Regulations
Biocompatibility Workshop: Biological Evaluation Execution & Authorship Training
In Vitro Diagnostic Regulations
11:10 - 12:10
Power Hour: Maintaining and Repairing Legacy Devices
- With the abundance of MDD devices and components still available on the market, is MDR certification always commercially necessary for a legacy device?
- What kind of maintenance and repairs can be performed without triggering a significant change?
- Planning ahead: creating a plan for maintenance and transition
- Erik Vollebregt - Partner, Axon Lawyers
12:10 - 12:40
The role and responsibilities of the PRRC
- Regulatory requirements
- Who needs to have a PRRC
- Qualifications to be a PRRC
- Responsibilities and Liability of a PRRC
- Knowledge gained from interactions with Notified Bodies and Competent Authorities
- Elem Ayne - President, TEAM-PRRC
11:10 - 11:55
II: Process in creating a Biological Evaluation Plan
- Utilizing Design inputs
- How to properly define intended use and device categorization
- Literature search
- How to reference competitive devices
- Clinical evaluation data integration
- Group divisions and BEP creation exercise
- Marina Daineko - Biocompatibility Consultant, Intrinsic Medical Group, LLC
11:55 - 12:40
III: Test design for BEP
- E&L test requirements and set up
- Correct Dose Base Threshold (DBT) for device
- Calculation of Analytical Evaluation Threshold (AET)
- Method Uncertainty Factor (UF), sensitivity, solvent selection
- Applying to intended use and materials
- Traditional endpoint tests and critical factors
- In-vitro vs In-vivo
- Extraction time, temp, and ratios.
- Determining gaps from E&L, literature, etc to determine appropriate endpoint test
- Group division and BEP completion
- Crystal D'Silva - Preclinical Technical Lead/Associate Director, Baxter
11:10 - 11:40
In Vitro Diagnostics in Precision Medicine Clinical Trials: Strategies for Success
- Brief overview of the regulatory requirements for implementing IVDs/CDx in a precision medicine trial
- Key considerations for Sponsors planning precision medicine clinical trials
- Lessons learned from using CDx in clinical trials in the EU & US
- James Lappin - Head of Clinical Compliance and Quality Assurance, ARC Regulatory Limited
11:40 - 12:40
A Deeper Dive: Regulating Laboratory Developed Tests (LDTs) in the EU & US
- Defining LDTs
- Where are LDTs covered in both European and US legislation?
- Overview of proposed rule from the FDA & impact for industry
- Replacement of proposed VALID Act
- Impact of IVDR on clinical trials
- Do commercial labs qualify?
- Jai Pandey - Global Device Regulatory Head for In-Vitro Diagnostics and Digital Health, Sanofi
- Lakshman Ramamurthy, PhD - Vice President, Regulatory Affairs, GRAIL
- Elizabeth Macintyre - President, Biomedical Alliance in Europe
12:40 - 13:40
Networking Luncheon & MedTech Showcase
Showing 1 of 1 Streams
MedTech Showcases
13:40 - 13:50
Regulatory Compliance of Medical Devices Requires a Multidisciplinary Approach
- Farah Ahmed - Principle Consultant, Exponent
- Greg Grigoriadis - Senior Associate Consultant, Exponent
13:50 - 14:00
RegDesk MedTech Showcase
Showing 3 of 3 Streams
European Medical Device Regulations
Biocompatibility Workshop: Biological Evaluation Execution & Authorship Training
In Vitro Diagnostic Regulations
14:10 - 14:15
Chairperson’s Afternoon Remarks: European Medical Device Regulations
- James Shearn - Director, Regulatory & Quality Compliance (EMEA), Steris
14:15 - 14:45
Regulatory Submission and Documentation: Path, Pitfalls and The Use of Artificial Intelligence
- Exploring the most common regulatory submission preparation pathways
- Discussing concerns regarding the current method of submission
- Looking at where regulatory submission and AI interlink and how this can streamline submissions
- Uncovering which parts of the regulatory submissions process can utilize AI most effectively
- Sharing resources and practical tips for implementation
- Priya Bhutani - CEO, RegDesk
14:45 - 15:15
The Latest News: European Health Data Space (EHDS)
- With the approval timeline expected in Q2 2024, what do we already know about the EHDS?
- Expected responsibilities of regulators, notified bodies and manufacturers
- Where does this link into the MDR & IVDR?
- Link to pharmaceutical industry
- Putting the EHDS into practice: a working example
- Cécile van der Heijden - Senior Attorney-at-Law, Axon Lawyers
15:15 - 15:45
GS1 and UDI Implementation under the EU MDR
- Introduction to GS1 as Issuing Agency
- Implementation of GS1 standards for Medical Devices. How to verify that the UDI-DI and B-UDI are valid? Latest information on Master UDI-DI.
- GS1 Belgium & Luxembourg solution to publish B-UDI and UDI-DI to the EUDAMED module Devices
- Patrick Ponsaerts - Manager Healthcare, GS1 Belgium & Luxembourg
14:10 - 14:15
Chairperson’s Afternoon Remarks: Biocompatibility Workshop
- Beau Rollins - Director, Quality Services, ConvaTec
- Marina Daineko - Biocompatibility Consultant, Intrinsic Medical Group, LLC
14:15 - 15:00
IV: Understanding and interpreting test results
- E&L test reports and applying AET for compound analysis
- Acceptance criteria for traditional endpoint tests
- Common deviations
- What to do if you fail
- Beau Rollins - Director, Quality Services, ConvaTec
15:00 - 15:45
V:Transitioning into a Biological Evaluation Report
- Addition of all test data and results determination
- Gap assessment to data, deviations, historical testing
- Developing a final conclusion
- Group division and BER completion
- Marina Daineko - Biocompatibility Consultant, Intrinsic Medical Group, LLC
14:10 - 14:15
Chairperson’s Afternoon Remarks: In Vitro Diagnostic Regulations
- Stuart Angell - Chair of Regulatory Affairs Working Party & Member of the Executive Board, BIVDA
14:15 - 14:45
The Good, The Bad and The Regulatory: Supporting IVD Lifecycle Management with Evidence from Literature
- IVD lifecycle success requires insights-driven decisions across all stages, such as R&D, regulatory submissions, and post-market surveillance.
- Finding relevant evidence in published literature is crucial but challenging.
- Is there a place for AI in this?
- Nadège Krebs, PhD - Customer Consultant Embase, Elsevier
14:45 - 15:45
Multi-Stakeholder Discussion: Certifying Companion Diagnostics (CDx)
- Current requirements for approving CDx
- Navigating both IVDR and EMA requirements
- Route to market
- Required data and documentation
- Hurdles and solutions along the way
- Future considerations
- Jörg Engelbergs - Scientific-Regulatory Expert Targeted & Personalized Biomedicines, Paul-Ehrlich-Institut
- Jai Pandey - Global Device Regulatory Head for In-Vitro Diagnostics and Digital Health, Sanofi
- Vihanga Pahalawatta - Director Regulatory Affairs Companion Diagnostics, AbbVie
- Heike Möhlig-Zuttermeister - Director Expertise Management & Segment Manager IVD, TÜV SÜD
15:45 - 16:15
Coffee and Networking Break
Showing 3 of 3 Streams
European Medical Device Regulations
Biocompatibility Workshop: Biological Evaluation Execution & Authorship Training
In Vitro Diagnostic Regulations
16:15 - 16:45
The Current Challenges in the Benefit-Risk Determination of Medical Devices
- Berkin Güler, B. Sc. - Manager Medical Device Consulting & Lead Auditor, NSF Medical Device & IVD Consulting
16:45 - 17:15
Recruitment & Retainment: Ensuring Sustainability from the Inside Out
- With MDR now in full swing, how are teams coping with the workload?
- Impact of MDR on budgets and recruitment
- How can teams ensure employees remain happy and healthy at work?
- Strategies for coping with increased workloads on the same teams
- Giacomo Cargnello - Head of Quality & Regulatory, Connect&Control Solutions, Varex Imaging
- Tatsiana Ripich - Head of Regulatory Affairs, enmodes GmbH
17:15 - 18:00
EU MDR Open Forum: Ask the Experts
Have burning questions left over from the last 2 days? Take the opportunity to connect with our speakers and raise those final questions in our ‘Ask the Experts’ panel!
- Gert Bos - Executive Director & Partner, Qserve Group
- Giacomo Cargnello - Head of Quality & Regulatory, Connect&Control Solutions, Varex Imaging
- Daniel Delfosse - Executive Board Member, Director Regulatory Affairs, Swiss Medtech
- Tatsiana Ripich - Head of Regulatory Affairs, enmodes GmbH
- Richard Houlihan - Founder & CEO, EirMed
- Patrick Ponsaerts - Manager Healthcare, GS1 Belgium & Luxembourg
16:15 - 16:45
VI: Toxicology Section
- Evaluating compounds
- NOAEL/LOAEL
- Cramer categorization
- Unknown determination
- MOS calculation per ISO 10993-17
- Group division and Tox assessment
- Ron Brown - Toxicologist, Risk Science Consortium
16:45 - 17:50
VII: Life of the Biological Evaluation
- Beau Rollins - Director, Quality Services, ConvaTec
16:15 - 18:00
Multi-Stakeholder Perspective: How the IVDR is Impacting Innovation & Industry
- How has the introduction of the IVDR influenced innovation?
- Is there a lack of innovation in Europe?
- Why?
- Pathways for industry to expedite market access – international recognition pathways
- How do innovation pathways in Europe compare to other regions?
- Future of diagnostic innovation
- How can all stakeholders encourage innovation in Europe?
- What is the risk of a fall in innovation?
- Andreas Stange - Senior Vice President MHS Regulatory & Quality, TÜV SÜD Product Service GmbH
- Marta Carnielli - Head of Certification IVD, TÜV SÜD Product Service GmbH
- Rolf Thermann - Section Manager IVD and Companion Diagnostics Lead, TUV Rhineland
- Sascha Wettmarshausen - Deputy Managing Director, Verband der Diagnostica-Industrie e.V (VDGH)
- Christa Cobbaert - Head of Department of Clinical Chemistry, Leiden University Medical Center
- Olga Tkachenko - Policy Officer, EU-Commission
18:00 - 19:00
Close of Day Two and Networking Reception
Get the Latest Event Updates
Sign up to get the latest event updates and information.
Filter
Streams